Description

Respibron (Haemophilus influenzae, Streptococcus pneumoniae) sublingual tablets #30

Composition

Respibron sublingual tablets contain active ingredients that target specific bacteria, such as Haemophilus influenzae and Streptococcus pneumoniae. These tablets are designed to be dissolved under the tongue for quick absorption into the bloodstream. Each tablet is formulated to provide the necessary concentration of antibiotics to combat respiratory infections effectively.

Uses

Respibron sublingual tablets are primarily used for the treatment of respiratory infections caused by Haemophilus influenzae and Streptococcus pneumoniae. These tablets are effective in fighting bacterial infections in the throat, lungs, and airways. Respibron can help alleviate symptoms such as cough, sore throat, fever, and difficulty breathing associated with these infections.

Dosage

The recommended dosage of Respibron sublingual tablets is one tablet taken under the tongue every 6 to 8 hours. It is important to follow the prescribed dosage and frequency as directed by your healthcare provider. Do not exceed the recommended dosage unless advised by a medical professional.

Side Effects

While Respibron is generally well-tolerated, some individuals may experience side effects when taking this medication. Common side effects may include nausea, vomiting, diarrhea, headache, and dizziness. If you experience any severe or persistent side effects, discontinue the medication and consult your doctor immediately.

Precautions

Before taking Respibron sublingual tablets, inform your healthcare provider about any existing medical conditions or allergies you may have. It is important to disclose all medications you are currently taking to avoid potential drug interactions. Pregnant or breastfeeding women should consult their doctor before using Respibron.

It is essential to complete the full course of treatment with Respibron as prescribed by your healthcare provider, even if you start feeling better before the course is completed. Stopping the medication prematurely can lead to the recurrence of the infection or the development of antibiotic-resistant strains of bacteria.

Conclusion

In conclusion, Respibron sublingual tablets are a valuable medication for the treatment of respiratory infections caused by Haemophilus influenzae and Streptococcus pneumoniae. By following the prescribed dosage and precautions, you can effectively manage these infections and alleviate associated symptoms. If you have any concerns or questions about Respibron, do not hesitate to consult your healthcare provider for personalized guidance.

Remember, this guide provides general information about Respibron sublingual tablets. For specific advice tailored to your individual needs, always consult a healthcare professional.